-
Biologics: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutic vaccines for malignant brain tumors
Review
(3085) Views (544) Full article downloads
Authors: Michael P Gustafson, Keith L Knutson, Allan B Dietz
Published Date December 2008
Volume 2008:2(4) Pages 753 - 761
DOI: http://dx.doi.org/10.2147/BTT.S3197
Michael P Gustafson1, Keith L Knutson2, Allan B Dietz1
1Division of Transfusion Medicine; 2Department of Immunology, Mayo Clinic, Rochester, MN, USA
Abstract: Malignant gliomas are the most common and aggressive form of brain tumors. Current therapy consists of surgical resection, followed by radiation therapy and concomitant chemotherapy. Despite these treatments, the prognosis for patients is poor. As such, investigative therapies including tumor vaccines have targeted this devastating condition. Recent clinical trials involving immunotherapy, specifically dendritic cell (DC) based vaccines, have shown promising results. Overall, these vaccines are well tolerated with few documented side effects. In many patients receiving vaccines, tumor progression was delayed and the median overall survival of these patients was prolonged. Despite these encouraging results, several factors have limited the efficacy of DC vaccines. Here we discuss the potential of DC vaccines as adjuvant therapy and current obstacles of generating highly pure and potent DC vaccines in the context of malignant glioma. Taken together, the results from earlier clinical studies justify additional clinical trials aimed at improving the efficacy of DC vaccines.
Keywords: malignant glioma, glioblastoma multiforme, vaccine, immunotherapy, dendritic cells
Readers of this article also read:
Evidence-based decision-making within the context of globalization: A “Why–What–How” for leaders and managers of health care organizations
Age-related disruption of the lamina dura: Evidence in the mandibular horizontal incompletely impacted third molar
Health literacy and health seeking behavior among older men in a middle-income nation
Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines
Corrigendum - Functional mobility and balance in community dwelling elderly submitted to multisensory versus strength exercises
Age- and tissue-specific variation of X-inactivation ratios in X-linked Alport syndrome females
Corrigendum
Adverse drug reaction suggests by a clinical vignette
Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Journal Indexing
See where all the Dove Press journals are indexed
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




